Kyndryl Holdings faces a securities fraud class action lawsuit after the company announced on February 9, 2026 that its CFO and General Counsel departed immediately, it cannot timely file its quarterly report, and it is under SEC investigation regarding cash management practices and internal controls. The stock fell 54.9% on the news. Investors have until April 13, 2026 to file a lead plaintiff motion.
Kyndryl Holdings, Inc. (KD)
Common Stock · Currency in USD · XNYS
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.
Company Info
SIC7373
Composite FIGIBBG012W99DN6
CIK0001867072
IPOOct 22, 2021
Sectorservices-computer integrated systems design
Highlights
Market Cap$2.98B
EPS$1.00
P/E Ratio13.08
Revenue$15.16B
Gross Profit$3.37B
Net Income$228.00M
Employees73,000
WSO225,447,192
Phone(855) 596-3795
Websitehttps://www.kyndryl.com
Related Tickers
Analysis
Share Price Chart
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Kyndryl Holdings, Inc., comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.
Returns By Period
Kyndryl Holdings, Inc. (KD) has returned -50.67% so far this year and -51.09% over the past 12 months. Looking at the last ten years, KD has achieved an annualized return of -7.36%, underperforming the Benchmark (SPY), which averaged 12.23% per year.
KD
1M0.38%
6M-56.24%
YTD-50.67%
1Y-51.09%
5Y-14.17%
10Y-7.36%
Benchmark (SPY)
1M-3.85%
6M-2.35%
YTD-4.36%
1Y34.06%
5Y9.80%
10Y12.23%
Monthly Returns
The table below presents the monthly returns of Kyndryl Holdings, Inc. (KD) with color gradation from worst to best to easily spot seasonal factors.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.24% | -46.23% | 8.16% | -0.30% | ||||||||
| 2025 | 9.30% | 2.84% | -17.99% | 3.48% | 18.30% | 7.56% | -9.73% | -14.20% | -3.50% | -3.54% | -10.90% | 4.12% |
| 2024 | 0.44% | 6.81% | -1.09% | -9.11% | 32.72% | -1.97% | 2.13% | -9.68% | -2.05% | -0.17% | 50.26% | 0.20% |
| 2023 | 18.71% | 17.44% | -5.75% | -1.30% | -12.60% | 6.33% | 3.17% | 25.04% | -10.60% | -2.47% | 23.07% | 15.96% |
| 2022 | -8.71% | -5.99% | -16.27% | -9.72% | 4.58% | -20.68% | 7.94% | -0.48% | -19.63% | 15.26% | 17.93% | -5.36% |
| 2021 | -44.39% | 10.43% |
Performance Indicators
The charts below present risk-adjusted performance metrics for Kyndryl Holdings, Inc. (KD) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
Sharpe ratio
Sortino ratio
Omega ratio
Calmar ratio
Martin ratio
sharpe ratio
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of KD compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
Volatility Chart
The current Kyndryl Holdings, Inc. volatility is 2.64%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
Income Statement
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
| 2025 | 2023 | 2021 | |
|---|---|---|---|
| Liabilities And Equity (USD) | 10.45B | 11.46B | 13.21B |
| Equity Attributable To Parent (USD) | 1.22B | 1.37B | 2.70B |
| Equity Attributable To Noncontrolling Interest (USD) | 113.00M | 97.00M | 3.00M |
| Equity (USD) | 1.33B | 1.46B | 2.70B |
| Noncurrent Liabilities (USD) | 4.82B | 5.13B | 5.97B |
| Other Current Liabilities (USD) | 2.30B | 2.56B | 3.02B |
| Wages (USD) | 652.00M | 533.00M | 381.00M |
| Accounts Payable (USD) | 1.35B | 1.77B | 1.14B |
| Current Liabilities (USD) | 4.30B | 4.87B | 4.54B |
| Liabilities (USD) | 9.12B | 10.00B | 10.51B |
| Other Non-current Assets (USD) | 3.29B | 3.72B | 4.51B |
| Fixed Assets (USD) | 2.57B | 2.78B | 2.92B |
| Noncurrent Assets (USD) | 5.86B | 6.50B | 7.44B |
| Current Assets (USD) | 4.59B | 4.96B | 5.78B |
| Assets (USD) | 10.45B | 11.46B | 13.21B |
News and Insights
Kirby McInerney LLP has filed securities fraud class action lawsuits against ImmunityBio, Kyndryl Holdings, and Super Micro Computer on behalf of investors. ImmunityBio faces allegations that Executive Chairman Patrick Soon-Shiong materially overstated capabilities of its Anktivas immunotherapy product. The FDA issued a warning letter on March 24, 2026, stating the company's marketing materials were false or misleading, causing ImmunityBio's stock to decline 21.2%. Investors have until specified deadlines to request lead plaintiff appointment.
Q1 2026 marked a dramatic market shift with oil surging 84% while Bitcoin plummeted 23%, signaling a rotation away from mega-cap growth toward real assets and energy. AI infrastructure plays like SanDisk and Lumentum soared on strong demand, while richly valued software and speculative growth stocks faced significant de-rating. The quarter demonstrated that traditional hedges and narratives are no longer reliable, with cash flow and tangible assets becoming increasingly important.
Kahn Swick & Foti, LLC announced multiple class action securities fraud lawsuits against Enphase Energy, Soleno Therapeutics, and Kyndryl Holdings. Enphase faces allegations of overstating inventory management capabilities and financial prospects between April-October 2025, with an April 20, 2026 deadline for lead plaintiff applications. Similar lawsuits were filed against Soleno (May 5, 2026 deadline) and Kyndryl (April 13, 2026 deadline).
Kahn Swick & Foti, LLC announces class action securities lawsuits against Kyndryl Holdings for alleged securities fraud between August 1, 2024 and February 9, 2026. On February 9, 2026, Kyndryl disclosed it could not timely file its Form 10-Q and anticipated reporting material weaknesses in internal controls, leading to a 55% stock price decline ($12.90 per share drop to $10.59). The company also experienced departures of its CFO and General Counsel. Investors have until April 13, 2026 to request lead plaintiff status.
Pomerantz Law Firm has filed class action lawsuits against PayPal Holdings, NuScale Power Corporation, and Kyndryl Holdings, alleging securities fraud and unlawful business practices. PayPal disclosed disappointing Q4 2025 earnings, worsening Branded Checkout performance, CEO departure, and withdrawn 2027 guidance. Investors have until April 20, 2026, to request Lead Plaintiff status.
Pomerantz Law Firm has filed class action lawsuits against Kyndryl Holdings, NuScale Power Corporation, and PayPal Holdings for alleged securities fraud and unlawful business practices. Kyndryl faced a 55% stock price drop following an SEC investigation disclosure and the departure of its CFO, General Counsel, and Global Controller on February 9, 2026. Investors have until April 13, 2026, to request Lead Plaintiff status.
Rosen Law Firm is notifying investors about ongoing securities class action lawsuits against Power Solutions International, Alight, Inc., and Kyndryl Holdings, Inc. The firm is encouraging eligible investors to join the litigation before upcoming lead plaintiff deadlines. Power Solutions faces allegations of overstating sales demand capabilities and understating manufacturing costs in the data center market.
Rosen Law Firm is soliciting investors who purchased securities in Kyndryl Holdings, Alight Inc., and Inovio Pharmaceuticals during specified periods to join class action lawsuits. The lawsuits allege that these companies made false statements, failed to disclose material information, and had inadequate internal controls, resulting in investor losses.
Hagens Berman has expanded a securities class action against Kyndryl Holdings (KD), alleging the company artificially inflated free cash flow metrics through undisclosed cash management practices to mask its true financial condition. The stock collapsed 55% following an SEC investigation disclosure and the departure of the CFO and General Counsel in February 2026. The expanded class period now covers August 1, 2024 through February 6, 2026.